Celcuity (CELC) Prepaid Assets (2017 - 2026)
Celcuity's (CELC) quarterly Prepaid Assets came in at $18.9 million in Q4 2025, up 600.37% YoY from $2.7 million in Q4 2024, and down 7.91% on a QoQ basis from $20.5 million in Q3 2025.
Celcuity (CELC) Prepaid Assets (2017 - 2026) Analysis & Trends
Celcuity (CELC) has 9 years of Prepaid Assets data on file, last reported at $18.9 million in Q4 2025.
- Quarterly Prepaid Assets rose 600.37% year-over-year to $18.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.9 million (up 600.37% YoY) and the FY2025 annual result came in at $18.9 million, up 600.37% from the prior year.
- Prepaid Assets fell to $18.9 million in Q4 2025, from $20.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $20.5 million in Q3 2025 to a low of $279544.0 in Q2 2021.
- A 5-year average of $7.0 million and a median of $6.6 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets soared 2750.65% — and 2024, when it slumped 73.04%.
- Tracing CELC's Prepaid Assets over 5 years: stood at $722677.0 in 2021, then slumped by 51.42% to $351073.0 in 2022, then soared by 2750.65% to $10.0 million in 2023, then tumbled by 73.04% to $2.7 million in 2024, then soared by 600.37% to $18.9 million in 2025.
- The last three Prepaid Assets figures came in at $18.9 million (Q4 2025), $20.5 million (Q3 2025), and $14.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.00 Mn |
| Dec 31, 2025 | 18.90 Mn |
| Sep 30, 2025 | 20.52 Mn |
| Jun 30, 2025 | 14.72 Mn |
| Mar 31, 2025 | 11.91 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Mar 31, 2024 | 9.86 Mn |
| Dec 31, 2023 | 10.01 Mn |
| Sep 30, 2023 | 7.77 Mn |
| Jun 30, 2023 | 6.46 Mn |
| Mar 31, 2023 | 6.53 Mn |
| Dec 31, 2022 | 351,073.00 |
| Sep 30, 2022 | 6.58 Mn |
| Jun 30, 2022 | 4.60 Mn |
| Mar 31, 2022 | 762,882.00 |
| Dec 31, 2021 | 722,677.00 |
| Sep 30, 2021 | 437,351.00 |
| Jun 30, 2021 | 279,544.00 |